Prexa Pharmaceuticals

Small molecule drugs for CNS diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2006 language prexainc.com

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 200 times.

YearFilings
20121
20151

Investor mix

2 investors on record; lead investors include Advent Life Sciences, Shire.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon